Abstract
Receptors have always been considered by pharmacologists as the “magic sites” where drugs elicit their therapeutic or toxic effects. Only recently, however, have suitable methods been developed to measure receptors. Developments have flourished particularly on the central nervous system (CNS) where receptors are considered an essential step both for neurotransmission mediated by chemical transmitters and for effects induced by drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. E. Leysen, W. Gommeren, P. M. Laduron, Spiperone: A ligand of choice for neuroleptic receptors. l. Kinetics and characteristics of in vitro binding,Biochem.Pharmacol.27: 307 (1978)
G. Scatchard, The attractions of proteins for small molecules and ions,Ann.N.Y.Acad.Sci.51: 660 (1949)
I. Creese, Receptor binding as a primary drug screening device,in“Neurotransmitter Receptor Binding” H. I. Yamamura, S. J. Enna, M: J. Kuhar, eds., Raven Press, New York (1978)
T. Mennini, S. Garattini, Benzodiazepine receptors’: Correlation with pharmacological responses in living animals,Life Sci. 31: 2025 (1982)
S. J. Peroutka, S. H. Snyder, Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding,Science210: 88 (1980)
K. Murugauah, A. Theodorou, S. Mann, A. Clow, P. Jenner and C. D. Marsden, Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum,Nature296: 570 (1982)
T. Mennini, E. Poggesi, S. Caccia, C. Bendotti, F. Borsini, R. Samanin, Adaptive changes in central serotonin receptors after long-term drug treatment in rats,in“Neurotransmitters and their Receptors”U. Z. Littauer, Y. Dudai, I, Silman, V. I. Teichberg, Z. Vogel, eds., Wiley & Sons, Chichester (1980)
P. W. Landffield, R. K. Baskin, and T. A. Pitler, Brain aging correlates: Retardation by hormonal-pharmacological treatmerits,Science214: 581 (1981)
A. De Blasi, S. Cotecchia, T. Mennini, Selective changes of receptor binding in brain regions of aged rats,Life Sci. 31: 335 (1982)
A. De Blasi, T. Mennini, Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats,Brain Res. 242: 361 (1982)
I. Hirschhorn, M. H. Makman, N. S. Sharpless, Dopamine receptor sensitivity following nigrostriatal lesion in aged rat,Brain Res. 234: 357 (1982)
J. A. Joseph, R E. Berger, B. T. Engel, and G. S. Roth, Age related changes in the nigrostriatum: A behavioural and biochemical analysis,J. Gerontol33: 643 (1978)
J. A. Joseph, C. R. Filburn, G. S. Roth, Development of dopamine receptor denervation supersensitivity-in the neostriatrum of the senescent rat,Life Sci. 29: 575 (1981)
P. Levin, J. K. Janda, J. Sv Joseph, D. K. Ingram, G. S. Roth, Dietary restriction retards. the age-associated loss of rat striatal dopaminergic receptors,Science21. 4: 561 (1981)
M. H. Makman, H. S. Ahn, L. J. Thal, N. S: Sharpless, B. Dvorkin, S. G. Horowitz, M Rosenfeld, Aging and monoamine receptors in brain,Fed.Proc38: 1922 (1979)
M. Memo, L. Lucchi, P. F. Spano, M. Trabucchi, Aging process affects a single class of dopamine receptors,Brain Res. 202: 488 (1980)
C. H. Misra, H. S. Shelat, R. C. Smith, Effect of age on adrenergic and dopaminergic receptor binding in rat brain,Life Sci. 27: 521 (1980)
C. H Misra, H. Shelat, R. C. Smith, Influence of age on the effects o f chronic f luphenazine on receptor binding in the rat brain,Eur.J.Pharmacol76: 317 (1981)
J. A. Severson, C. E. Finch, Reduced dopaminergic binding during aging in the rodent striatum,Brain Res. 192: 47 (1980)
L. J. Thal, S. G. Horowitz, B. Dvorkin, M. H. Makman, Evidence for loss of brain (3H) spiroperidol and (3H)ADTN binding sites in rabbit brain with aging,Brain Res. 192: 185 (1980)
J. F. Marshall, N. Berrios, Movement disorders of aged rats: Reversal by dopardne receptor stimulation,Science206: 477 (1979)
L. H. Greenberg, and B. Weiss, adrenergic receptors in aged rat brain: reduced number and capacity, of pineal gland to develop supersensitivity,Science201: 61 (1978)
A. Maggi, M. J. Schmidt, B. Ghetti, S. Enna, Effect of aging, on neurotransmitter receptor binding in rat and human brain,Life Sci. 24: 367 (1979)
B. Weiss,L. Greenberg, E. Cantor, Age-related alterations in the development of adrenergic denervation supersensitivity:,Fed.Proc38: 1915 (1979)
I. B: Abrass, and P. J. Scarpace, Human lymphocyte betareceptors are unaltered with age,J.Gerontol36: 298 (1981)
R. Landmann, H. Bittiger, F. R. BUhler, High affinity beta-2-adrenergic receptors in mononuclear leucocytes: Similar density in young and old normal subjects,Life Sci. 29: 1761 (1981).
P. K. Randall, J. A. Severson, C. E. Finch, Aging and the regulation of-striatal dopaminergic mechanisms in mice,J. Pharma. col. Exp. Ther219: 695 (1981)
M: Roffman, F. Cordasco, A. Kling, Apomorphine-induced stereotypy in mature and senescent rats following cessation of chronic ha-loperidol treatment,Conmun.Psychopharmacol. 4: 283 (1980)
S. Algeri, G. Calderini, G. Lomuscio, G. Toffano, F. Ponzio, Catecholamines and adaptive mechanisms in senescent rats,in“Apomorphine and other Dopaminomimetics, Vol. 2 Clinical Pharmacology” G. U. Corsini, G. L. Gessa, eds., Raven Press, New York (1981)
V. Jonec, and- C. F. Finch, Ageing and dopamine uptake by subcellular fractions of the C57BL/6J male mouse brain,Brain Res. 91: 197 (1975)
S. N. Pradhan, Central neurotransmitters and aging,Life Sci. 26: 1643 (1980)
E. G. McGeer, H. C. F biger, P. L. McGeer, V. Wickson, Aging and brain enzymes,Exp. Gerontol. 6: 391 (1971)
S. Govoni, P. Loddo, P. F. Spano, M. Trabucchi, Dopamine receptor sensitivity in brain and retina of rats during aging,Brain Res. 138: 565 (1977)
M. H. Makman, H. S. Ahn, L. J. Thal, N. S. Sharpless, B. Dvorkin, S. G. Horowitz, and M. Rosenfeld, Evidence for selective loss of brain dopamine-and histamine-stimulated adenylate cyclase activities in rabbits with aging,Brain Res. 192: 177 (1980)
J. K. Marquis, A-S Lippa, and R. W. Pelham, Dopamine receptor alterations with aging in mouse and rat corpus striatum.,Biochem.Pharmacol30: 1876 (1981)
J. E. Heusnery and H. B. Bosmann, GABA stimulation of 3H-diazepam binding in aged mice,Life Sci. 29: 71 (1981)
M. Memo, P. F. Spano, M. Trabucchi, Brain benzodiazepine receptor changes during ageing, J.Pharm.Pharmacol33: 64 (1981)
C. C. Tsang, K. V. Speeg Jr., C.R. Wilkinson, Aging and benzodiazepine binding in the rat cerebral cortex,Life Sci. 30: 343 (1982)
N. W. Pedigo, J. N. McDougal, T. F. Burks, H. I. Yamamura, Benzodiazepine receptor binding in frontal cortex and cerebellum from aged rat,Fed:Proc. 40: 311 (1981)
N. W. Pedigo,H. Schoemaker, M. Morelli, J. N. McDougal, J. B. Malick, T. F. Burks, H. I. Yamamura, Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney, Neurobiol.Aging 2: 83 (1981)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Garattini, S., de Blasi, A. (1984). Brain Receptors and Aging in Relation to Drug Effect. In: Barbagallo-Sangiorgi, G., Exton-Smith, A.N. (eds) Aging and Drug Therapy. Ettore Majorana International Science Series. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2791-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2791-2_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9721-5
Online ISBN: 978-1-4613-2791-2
eBook Packages: Springer Book Archive